Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Radiotherapy + Valproic acid |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Radiotherapy | ||||
| Valproic acid | Stavzor | Depacon|Valproate Sodium|Depakene | HDAC Inhibitor 45 | Valproic acid inhibits HDAC activity, potentially resulting in decreased angiogenesis, increased tumor cell differentiation, and reduced tumor growth (PMID: 11742974, PMID: 14978230). Valproic acid is FDA-approved for use in treating seizures (FDA.gov). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01898104 | Phase Ib/II | Capecitabine + Radiotherapy Radiotherapy + Valproic acid Capecitabine + Radiotherapy + Valproic acid Radiotherapy | Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer (V-shoRT-R3) | Unknown status | ITA | 0 |